Teladoc Health (TDOC) Depreciation & Amortization (CF) (2014 - 2026)

Teladoc Health has disclosed Depreciation & Amortization (CF) across 13 years of filings, most recently posting $2.5 million for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $2.5 million, down 30.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.2 million (up 11.89% YoY), and the FY2025 annual result was $13.3 million, up 30.75% from the prior year.
• Depreciation & Amortization (CF) came in at $2.5 million for Q1 2026 at Teladoc Health, down from $2.8 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $94.3 million in Q3 2023 to a low of $1.7 million in Q2 2024.
• The 5-year median for Depreciation & Amortization (CF) is $3.6 million (2025), against an average of $30.8 million.
• Across the five-year window, Depreciation & Amortization (CF) sank 97.74% in 2024 and jumped 154.73% in 2025, its largest moves.
• Teladoc Health's Depreciation & Amortization (CF) stood at $75.7 million in 2022, then slumped by 96.31% to $2.8 million in 2023, then advanced by 6.7% to $3.0 million in 2024, then retreated by 6.04% to $2.8 million in 2025, then decreased by 12.11% to $2.5 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $2.5 million (Q1 2026), $2.8 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.